Abstract:Objective:To establish stable and reliable rat models of hepatic cirrhosis with syndrome of liver depression and spleen deficiency,closely related to clinical disease and suitable for Chinese medicine active discovery and efficacy evaluation.Method:The 70 rats were randomly assigned to normal control group;model group Ⅰ (79.5％ simple corn flour plus 20％ lard,high fat and low protein feed composed of 0.5％ cholesterol;30％ alcohol compound factors for four weeks of modeling),silybin meglumine tablets group Ⅰ;modified model group Ⅱ (79.5％ simple corn flour plus 20％ lard,high fat and low protein feed composed of 0.5％ cholesterol;10％ alcohol gavage for 1 week,and 5％ alcohol gavage for 3 weeks for modeling),silybin meglumine tablets group Ⅱ;modified model group Ⅲ (89.5％ simple corn flour plus 10％ lard,high fat and low protein feed composed of 0.5％ cholesterol;10％ alcohol gavage for 1 week,and 5％ alcohol gavage for 3 weeks for modeling),and silybin meglumine slice group Ⅲ according to their body weight,n =10 in each group.The rats in Silibin meglumine tablets group Ⅰ,group Ⅱ and group Ⅲ received the treatment of silibin meglumine tablets at the dose of 0.108 g·kg-1by gavage administration.During the experimental period,rats in all the other groups except the normal control group received unexpected emotional stimuli.Their general state was observed daily in every group;the clinical syndrome of liver cirrhosis (liver stagnation and spleen deficiency syndrome) was simulated;the syndrome performance suitable for the rats were analyzed and put forward;and the scores were given according to the standard every day.In addition,the body weight of the rats,daily food intake and daily water intake were recorded.The contents of alanine aminotransferase (ALT),aspartate aminotransferase (AST),hyaluronic acid (HA),procollagen Ⅲ (PC Ⅲ),type collagenase Ⅳ (Ⅳ-C),adenosine deaminase (ADA),monoamine oxidase (MAO) and A/G in serum were detected in eyeball blood at the end of experiment;and histopathological changes of the liver tissues were observed with htoxylin-easin (HE) staining.Result:No rats died in the normal group,and the nutrition status was good.Water intake and food intake were decreased in model group,with slow weight gain,rough hair,apathetic,and toenail bleeding in individual mice.Four mice died in model group Ⅰ;three mice died in model group Ⅱ,and no death in model group Ⅲ.As compared with the normal group,the serum ALT,AST,HA,PC-Ⅲ,Ⅳ-C,ADA and MAO levels were significantly higher;A/G was significantly lower;and visceral brain ratio and syndrome scores were increased significantly in model group (P ＜ 0.01).As compared with the model group Ⅰ,serum ALT,AST,HA,PC-Ⅲ,Ⅳ-C,ADA and MAO levels were significantly lower;A/G was significantly higher;and visceral brain ratio and syndrome scores were decreased significantly in various treatment groups (P ＜ 0.05,P ＜ 0.01).The morphological examination of the liver tissues showed false lobule formation in model group,with typical periportal lesions,but the lesions showed different degrees of improvement in the positive drug group.Conclusion:The modified cirrhosis rat models with a low mortality can be induced in a short time and animal status was similar to clinical syndrome performance of patients.Therefore,the rat models were suitable for the activity discovery,efficacy evaluation and mechanism investigation for cirrhosis,and also can be used in the research of correlation between the prescription and syndrome.

Study on the Rat Model of Liver Depression Syndrome Established by Thyroxine Tablet and Irregularity of Food

[Research on Rat Models of Acute Liver Injury with Syndrome of Liver Depression and Spleen Deficiency].

Rat Models of Fatty Liver Due to Liver Depression and Spleen Deficiency

Comparison of the effects of single emotional stimulus and complex emotional stimuli on the rat model of liver depression syndrome

Establishment of Hepatic Cirrhosis Models with Syndrome of Liver Depression and Spleen Deficiency in Rats by Modified High Fat and Alcohol Stimulation and Emotional Stimuli

Study of Animal Model of Hepatic Fibrosis with Liver Stagnation and Spleen Deficiency Syndrome in Rats

Establishment of an Animal Model with Iodine and Iron Comitant Deficiency in Rat

Based on Change of Liver Function and Gastrointestinal Function in Rat Model with Liver Depression to Discuss The Objectivity of Strengthening Spleen When Treating Liver Disease Because Spleen Can Be Involved in

Establishment and evaluation of a rat model of co-occurring atherosclerosis and depression symptomatology

The role of dietetic treatment in non-alcoholic fatty liver disease of rats

Establishment of an animal model with hypoxic hepatitis

[Study on Construction of Rat Model of Acute Pancreatitis with Syndrome of Liver Depression and Qi Stagnation].

Establishment of a rat model of alcoholic liver disease

Liver metabolomic characteristics in three different rat models of deficiency based on ultra-performance liquid chromatography coupled to quadrupole time-of-flight mass spectrometry

Establishment of Diabetes Rat Model of Kidney Yin Deficiency

Establishment of a rat model of early-stage liver failure and Th17/Treg imbalance

The establishment of experimental model of fatty liver in rats induced by high fat diet

Evaluation of iron status in a non-alcoholic steatohepatitis rat model

Gut Microbial Diversity Analysis Using Illumina Sequencing for Functional Dyspepsia with Liver Depression-Spleen Deficiency Syndrome and the Interventional Xiaoyaosan in a Rat Model.

The study of Scrophulariaceae ethanol extract on the exterior signs of mice model induced by thyroxine

Rat Model Of Nonalcoholic Steatohepatitis With Fibrosis By A Fat-Rich Diet